WCM Investment Management Portfolio holdings
AUM
$48.6B
1-Year Est. Return
43.05%
This Fund
S&P 500
1 Year Est. Return
+43.05%
AUM
$48.6B
AUM Growth
+$504M
(+1%)
Holding
263
Top Buys
| 1 | +$1.08B | |
| 2 | +$1.05B | |
| 3 | +$759M | |
| 4 |
Welltower
WELL
|
+$586M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$339M |
Top Sells
| 1 | +$561M | |
| 2 | +$453M | |
| 3 | +$433M | |
| 4 |
Steris
STE
|
+$288M |
| 5 |
Applovin
APP
|
+$117M |
Sector Composition
| 1 | Technology | 26.66% |
| 2 | Financials | 17.64% |
| 3 | Consumer Discretionary | 15.56% |
| 4 | Industrials | 10.89% |
| 5 | Communication Services | 9.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Commault Systems
CVLT
$3.74B
| $15.3M | 0.03% |
120,362
-7,452
|
|
||
127
AtriCure
ATRC
$1.56B
| $15M | 0.03% |
372,682
+46,961
|
|
||
128
ICF International
ICFI
$1.53B
| $14.9M | 0.03% |
171,972
-35,587
|
|
||
129
Dycom Industries
DY
$12.6B
| $14.5M | 0.03% |
42,330
-11,220
|
|
||
130
Virtus Investment Partners
VRTS
$935M
| $14.4M | 0.03% |
87,812
-19,860
|
|
||
131
CBIZ
CBZ
$1.56B
| $14.1M | 0.03% |
274,630
-4,325
|
|
||
|
NBIS
132
Nebius Group N.V.
NBIS
$23.1B
| $13.9M | 0.03% |
163,365
+25,172
|
|
||
133
Avient
AVNT
$3.76B
| $13.9M | 0.03% |
440,663
-24,871
|
|
||
134
Cognex
CGNX
$9.01B
| $13.8M | 0.03% |
380,130
-64,853
|
|
||
135
BridgeBio Pharma
BBIO
$12.9B
| $13.2M | 0.03% |
174,588
-86,394
|
|
||
136
Axogen
AXGN
$1.59B
| $13.1M | 0.03% |
+400,616
|
|
||
137
iRhythm Holdings
IRTC
$4.32B
| $13.1M | 0.03% |
73,292
-3,969
|
|
||
138
Penumbra
PEN
$13.5B
| $12.9M | 0.03% |
41,053
-2,105
|
|
||
139
Interparfums
IPAR
$3.23B
| $12.5M | 0.03% |
148,055
-33,443
|
|
||
140
Bio-Techne
TECH
$9.23B
| $12.2M | 0.03% |
206,542
-10,838
|
|
||
141
Ducommun
DCO
$1.85B
| $12.1M | 0.02% |
+126,746
|
|
||
142
Insight Enterprises
NSIT
$2.59B
| $11.9M | 0.02% |
142,888
-5,081
|
|
||
143
Sony
SONY
$138B
| $11.5M | 0.02% |
445,557
+284,629
|
|
||
144
Glaukos
GKOS
$6.99B
| $11.1M | 0.02% |
97,367
-5,520
|
|
||
145
Guardant Health
GH
$12.3B
| $10.9M | 0.02% |
+107,931
|
|
||
146
Sabesp
SBS
$21B
| $10.7M | 0.02% |
442,683
+183,893
|
|
||
147
Repligen
RGEN
$7.25B
| $10.6M | 0.02% |
63,604
-4,395
|
|
||
148
Clearwater Analytics
CWAN
$6.88B
| $10.4M | 0.02% |
432,025
-187,115
|
|
||
149
Haleon
HLN
$49.3B
| $10.2M | 0.02% |
1,013,242
+526,609
|
|
||
150
Madrigal Pharmaceuticals
MDGL
$9.81B
| $10.1M | 0.02% |
17,254
-1,037
|
|